(VIANEWS) – Gentherm (THRM), Agree Realty Corporation (ADC), Pfizer (PFE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Gentherm (THRM)
35% sales growth and 8.47% return on equity
Gentherm Incorporated designs, develops, manufactures, and markets thermal management technologies. The company operates through two segments, Automotive and Medical. The Automotive segment offers climate comfort system solutions, which include seat heaters, blowers, and thermoelectric devices for variable temperature climate control seats and steering wheel heaters that are designed to provide thermal comfort to automobile passengers; integrated electronic components, such as electronic control units that utilize proprietary electronics technology and software; and other climate comfort system solutions, including neck conditioners and climate control system products for door panels, armrests, cupholders, and storage bins. It also provides battery performance solutions, including cell connecting devices for various types of automotive batteries, as well as thermal management products for heating and cooling 12V, 48V, and high voltage batteries and battery modules; and automotive electronic and software systems comprising electronic control units for climate comfort systems, as well as for memory seat modules and other devices. This segment serves light vehicle original equipment manufacturers (OEMs), commercial vehicle OEMs, and first tier suppliers to the automotive OEMs, including automotive seat manufacturers, as well as aftermarket seat distributors and installers. The Medical segment offers patient temperature management systems. The company provides its products and services in the United States, Germany, Canada, China, Hungary, Japan, Korea, the Czech Republic, Macedonia, Malta, Mexico, the United Kingdom, Ukraine, and Vietnam. The company was formerly known as Amerigon Incorporated and changed its name to Gentherm Incorporated in September 2012. Gentherm Incorporated was incorporated in 1991 and is headquartered in Northville, Michigan.
Earnings Per Share
As for profitability, Gentherm has a trailing twelve months EPS of $2.44.
PE Ratio
Gentherm has a trailing twelve months price to earnings ratio of 29.7. Meaning, the purchaser of the share is investing $29.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.47%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 3.9% and 9.8%, respectively.
Yearly Top and Bottom Value
Gentherm’s stock is valued at $72.56 at 05:22 EST, way below its 52-week high of $91.54 and way higher than its 52-week low of $49.45.
Moving Average
Gentherm’s worth is above its 50-day moving average of $70.28 and way higher than its 200-day moving average of $64.66.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2%, now sitting on 1.02B for the twelve trailing months.
2. Agree Realty Corporation (ADC)
18.7% sales growth and 3.8% return on equity
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.83.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 40.87. Meaning, the purchaser of the share is investing $40.87 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.8%.
Volume
Today’s last reported volume for Agree Realty Corporation is 819461 which is 28.48% below its average volume of 1145800.
Moving Average
Agree Realty Corporation’s worth is higher than its 50-day moving average of $72.62 and higher than its 200-day moving average of $71.70.
Revenue Growth
Year-on-year quarterly revenue growth grew by 27.5%, now sitting on 429.81M for the twelve trailing months.
3. Pfizer (PFE)
14.6% sales growth and 36.87% return on equity
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Pfizer has a trailing twelve months EPS of $1.71.
PE Ratio
Pfizer has a trailing twelve months price to earnings ratio of 25.31. Meaning, the purchaser of the share is investing $25.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.87%.
Sales Growth
Pfizer’s sales growth for the next quarter is 14.6%.
Moving Average
Pfizer’s worth is way below its 50-day moving average of $48.34 and way under its 200-day moving average of $48.48.
Yearly Top and Bottom Value
Pfizer’s stock is valued at $43.21 at 05:22 EST, way under its 52-week high of $56.32 and above its 52-week low of $41.45.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 25, 2023, the estimated forward annual dividend rate is 1.64 and the estimated forward annual dividend yield is 3.76%.
4. CBOE Holdings (CBOE)
10.7% sales growth and 7.1% return on equity
Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, Europe and Asia Pacific, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities. This segment also offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The Europe and Asia Pacific segment offers pan-European listed equities and derivatives transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, CBOE Holdings has a trailing twelve months EPS of $2.24.
PE Ratio
CBOE Holdings has a trailing twelve months price to earnings ratio of 55.47. Meaning, the purchaser of the share is investing $55.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.1%.
Yearly Top and Bottom Value
CBOE Holdings’s stock is valued at $124.26 at 05:22 EST, under its 52-week high of $130.54 and way higher than its 52-week low of $103.82.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 3.5% and 3.5%, respectively.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Nov 28, 2022, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 1.63%.
5. Ciena Corporation (CIEN)
9.6% sales growth and 5.33% return on equity
Ciena Corporation provides network hardware, software, and services that support the transport, routing, switching, aggregation, service delivery, and management of video, data, and voice traffic on communications networks worldwide. The company's Networking Platforms segment offers hardware networking products and solutions that optimized for the convergence of coherent optical transport, optical transport network switching, and packet switching. Its products include 6500 Packet-Optical Platform, 5430 Reconfigurable Switching System, Waveserver stackable interconnect system, and the 6500 Reconfigurable line system, and the 5400 family of Packet-Optical platforms, as well as Z-Series Packet-Optical Platform; 3000 family of service delivery switches and service aggregation switches, and the 5000 family of service aggregation switches, as well as 8700 Packetwave Platform and the Ethernet packet configuration for the 5410 Service Aggregation Switch; and 6500 Packet Transport System. This segment also sells operating system software and enhanced software features embedded in each of its products. The company's Blue Planet Automation Software and Services segment provides multi-domain service orchestration, inventory, route optimization and analysis, network function virtualization orchestration, analytics, and related services. Its Platform Software and Service segment offers OneControl unified management system and platform software services, as well as manage, control, and plan software. The company's Global Services segment provides consulting and network design, installation and deployment, maintenance support, and training services. The company sells its products through direct and indirect sales channels to network operators. Ciena Corporation was founded in 1992 and is headquartered in Hanover, Maryland.
Earnings Per Share
As for profitability, Ciena Corporation has a trailing twelve months EPS of $1.
PE Ratio
Ciena Corporation has a trailing twelve months price to earnings ratio of 47.75. Meaning, the purchaser of the share is investing $47.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.33%.
Volume
Today’s last reported volume for Ciena Corporation is 848759 which is 50.32% below its average volume of 1708740.
6. Broadcom (AVGO)
6% sales growth and 48.2% return on equity
Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; embedded processors and controllers; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was incorporated in 2018 and is headquartered in San Jose, California.
Earnings Per Share
As for profitability, Broadcom has a trailing twelve months EPS of $8.65.
PE Ratio
Broadcom has a trailing twelve months price to earnings ratio of 68.97. Meaning, the purchaser of the share is investing $68.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.2%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 20.6% and 7.5%, respectively.
Volume
Today’s last reported volume for Broadcom is 1015170 which is 54.84% below its average volume of 2248270.
Sales Growth
Broadcom’s sales growth is 15.4% for the present quarter and 6% for the next.
